calendar
5,164 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion
5,164 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion
no tagged catalysts yet
Sponsor: University of Nottingham. Phase: . Conditions: Diabete Mellitus, Type 1 Diabetes Mellitus
Sponsor: Affiliated Hospital of Jiaxing University. Phase: NA. Conditions: Apneic Oxygenation
Sponsor: University of Utah. Phase: NA. Conditions: Pneumonia, Urinary Tract Infection, Antibiotic Stewardship, Care Transition
Sponsor: Suzhou Raymon Pharmaceuticals Company, Ltd.. Phase: PHASE2. Conditions: Pterygium
Sponsor: GlaxoSmithKline. Phase: PHASE3. Conditions: Lung Diseases, Interstitial
Sponsor: The Lymphoma Academic Research Organisation. Phase: PHASE2. Conditions: Primary CNS Lymphoma (PCNSL)
Sponsor: The Cleveland Clinic. Phase: . Conditions: Heart Failure, Socioeconomic Adversity
Sponsor: Sanliurfa Mehmet Akif Inan Education and Research Hospital. Phase: NA. Conditions: Interscalene Block, Superficial Cervical Block, Cerebral Perfusion, Shoulder Surgeries
Sponsor: Paul E Schulz. Phase: PHASE1. Conditions: Alzheimer Disease
Sponsor: Catholic University of Applied Sciences Mainz. Phase: NA. Conditions: Resilience, Psychological, Personnel, Hospital
Sponsor: Vrije Universiteit Brussel. Phase: . Conditions: Stroke, Cerebro-vascular Accident, Ischemia Stroke, Hemorrhage Stroke
Sponsor: University of Leipzig. Phase: PHASE2. Conditions: Acute Myeloid Leukemia (AML)
Sponsor: Ottawa Heart Institute Research Corporation. Phase: NA. Conditions: Coronary Artery Disease
Sponsor: Weill Medical College of Cornell University. Phase: PHASE1. Conditions: Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma, Diffuse Large B Cell Lymphoma
Sponsor: Jonsson Comprehensive Cancer Center. Phase: PHASE2. Conditions: DLL3-expressing Tumors, Advanced Tumors
Sponsor: Elsan. Phase: . Conditions: Bronchiolitis, Bronchiolitis Acute
Sponsor: National Cancer Institute (NCI). Phase: PHASE3. Conditions: Melanoma of Unknown Primary, Recurrent Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7
Sponsor: Capsida Biotherapeutics, Inc.. Phase: PHASE1. Conditions: Developmental and Epileptic Encephalopathy
Sponsor: iHealth Labs inc. Phase: . Conditions: Influenza A, Influenza B, COVID - 19, RSV
Sponsor: Abant Izzet Baysal University. Phase: NA. Conditions: Breast Cancer Related Lymphedema
Sponsor: Sana'a University. Phase: NA. Conditions: Acceleration of Tooth Movement
Sponsor: Massachusetts General Hospital. Phase: PHASE4. Conditions: Adrenoleukodystrophy, Restless Legs Syndrome
Sponsor: Niguarda Hospital. Phase: NA. Conditions: Heart Failure
Sponsor: Radboud University Medical Center. Phase: NA. Conditions: Parkinson Disease
Sponsor: Asan Medical Center. Phase: PHASE2. Conditions: Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
Sponsor: SEVAL CEYLAN ŞEN. Phase: NA. Conditions: Insufficient Keratinized Gingiva
Sponsor: Hagar Ahmed Ali Mohammed Elzain. Phase: PHASE1. Conditions: Periodontitis Stage III
Sponsor: Rhaeos, Inc.. Phase: NA. Conditions: Hydrocephalus
Sponsor: University of Michigan. Phase: NA. Conditions: Food Addiction
Sponsor: Mastelli S.r.l. Phase: NA. Conditions: Rotator Cuff Tendinopathy
Sponsor: Xijing Hospital. Phase: NA. Conditions: Postoperative Delirium (POD), Diabetes
Sponsor: European Institute of Oncology. Phase: . Conditions: Cancer Related Cognitive Impairment, Breast Cancer Survivors
Sponsor: Peking Union Medical College Hospital. Phase: NA. Conditions: Abortion, Induced
Sponsor: Laboratorios Pisa S.A. de C.V.. Phase: PHASE1. Conditions: Healthy Subjects
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Retroperitoneal Sarcoma
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano. Phase: . Conditions: Epithelioid Hemangioendothelioma, Sarcoma,Soft Tissue
Sponsor: University of Michigan. Phase: NA. Conditions: Parkinson Disease
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.. Phase: PHASE1. Conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndromes (MDS)
Sponsor: Xinjiang Medical University. Phase: NA. Conditions: Cancer Therapy-Related Cardiac Dysfunction, Cardio-oncology, Cancer Survivorship, Cardiovascular Risk, Heart Failure
Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Health Status Unknown, Obesity
Sponsor: Roswell Park Cancer Institute. Phase: PHASE1. Conditions: Cigarette Smoking-Related Carcinoma
Sponsor: Benha University. Phase: NA. Conditions: Gastric Insufflation
Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Amyotrophic Lateral Sclerosis
Sponsor: Johns Hopkins University. Phase: NA. Conditions: Opioid Use Disorder
Sponsor: Kim, Seok Jin. Phase: PHASE2. Conditions: Primary CNS Lymphoma
Sponsor: Icahn School of Medicine at Mount Sinai. Phase: PHASE2. Conditions: Post-acute Sequelae of COVID-19, Long COVID
Sponsor: Shanghai Zhongshan Hospital. Phase: PHASE2. Conditions: Melanoma
Sponsor: Krystal Biotech, Inc.. Phase: PHASE1. Conditions: Cystic Fibrosis
Sponsor: Centre Antoine Lacassagne. Phase: NA. Conditions: Breast Cancer
Sponsor: Chengdu Kanghong Pharmaceutical Group Co., Ltd.. Phase: PHASE1. Conditions: Healthy Adult Participants